| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
HLA and MHCImmune system (Diseases)Receptor (Immunoglobulin like)Thymus leukemia antigen TL| 1 | 2005 | Clinical and immunological aspects of HLA class I deficiency. | 
| + | - | nl | QJM 98(10):719-27 (2005) |
| 2 | 2007 | The HLA system: genetics, immunology, clinical testing, and clinical implications. |
| + | - | nl | Yonsei Med J 48(1):11-23 (2007) |
| 3 | 1991 | Immunogenetics of the HLA system. |
| + | - | nl | Yonsei Med J 32(1):1-8 (1991) |
| 4 | 1990 | The major histocompatibility complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders. |
| + | - | nl | Yale J Biol Med 63(5):477-86 (1990) |
| 5 | 2005 | Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. |
| + | - | nl | Cell Microbiol 7(10):1398-403 (2005) |
| 6 | 1997 | How did the primordial T cell receptor and MHC molecules function initially? |
| + | - | nl | Immunol Cell Biol 75(2):193-6 (1997) |
| 7 | 1996 | Peptide binding function and the paradox of HLA disease associations. |
| + | - | nl | Immunol Cell Biol 74(5):444-8 (1996) |
| 8 | 1995 | Why do class I MHC molecules bind smaller peptides than class II MHC molecules? |
| + | - | nl | Immunol Cell Biol 73(1):95-7 (1995) |
| 9 | 1994 | Twenty years into the saga of MHC-restriction. |
| + | - | nl | Immunol Cell Biol 72(6):447-54 (1994) |
| 10 | 2008 | Manipulation of MHC-I/TCR interaction for immune therapy. |
| + | - | nl | Cell Mol Immunol 5(3):171-82 (2008) |
| 11 | 2004 | MHC class I antigen presentation--recently trimmed and well presented. |
| + | - | nl | Cell Mol Immunol 1(1):22-30 (2004) |
| 12 | 2007 | The final touches make perfect the peptide-MHC class I repertoire. |
| + | - | nl | Immunity 26(4):397-406 (2007) |
| 13 | 2003 | Stress management: MHC class I and class I-like molecules as reporters of cellular stress. |
| + | - | nl | Immunity 19(4):469-77 (2003) |
| 14 | 2005 | Paired immunoglobulin-like receptors and their MHC class I recognition. |
| + | - | nl | Immunology 115(4):433-40 (2005) |
| 15 | 1986 | Class I genes and molecules: an update. |
| + | - | nl | Immunology 57(1):3-18 (1986) |
| 16 | 2005 | Structure of the human class I histocompatibility antigen, HLA-A2. |
| + | - | nl | J Immunol 174(1):6-19 (2005) |
| 17 | 2009 | MHC II and the endocytic pathway: regulation by invariant chain. |
| + | - | nl | Scand J Immunol 70(3):184-93 (2009) |
| 18 | 2001 | MHC class II allosteric site drugs: new immunotherapeutics for malignant, infectious and autoimmune diseases. |
| + | - | nl | Scand J Immunol 54(1-2):39-44 (2001) |
| 19 | 1998 | Birth of the major histocompatibility complex. |
| + | - | nl | Scand J Immunol 47(3):199-209 (1998) |
| 20 | 2001 | How selection shapes variation of the human major histocompatibility complex: a review. |
| + | - | nl | Ann Hum Genet 65(Pt 1):1-26 (2001) |
| 21 | 2006 | The evolutionary ecology of the major histocompatibility complex. |
| + | - | nl | Heredity 96(1):7-21 (2006) |
| 22 | 2000 | The porcine major histocompatibility complex and related paralogous regions: a review. |
| + | - | nl | Genet Sel Evol 32(2):109-28 (2000) |
| 23 | 2009 | Does intra-individual major histocompatibility complex diversity keep a golden mean? |
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 364(1513):117-28 (2009) Woelfing B |
| 24 | 2004 | Non-immune functions of MHC class I glycoproteins in normal and malignant cells. |
| + | - | nl | Folia Biol (Praha) 50(2):35-42 (2004) |
| 25 | 2004 | Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen. |
| + | - | nl | Cancer Sci 95(6):469-74 (2004) |
| 26 | 1999 | Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules. |
| + | - | nl | Am J Pathol 154(3):651-64 (1999) |
| 27 | 1978 | The peritoneal fluid cytology of adult female dogs. |
| + | - | nl | Experientia 34(2):184-5 (1978) |
| 28 | 2002 | Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease. |
| + | - | nl | Arthritis Res 4(4):261-5 (2002) |
| 29 | 2001 | MHC class I multimers. |
| + | - | nl | Arthritis Res 3(5):265-9 (2001) |
| 30 | 2002 | HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. |
| + | - | nl | Arthritis Rheum 46(1):5-12 (2002) |
| 31 | 1997 | Evolving views of the major histocompatibility complex. |
| + | - | nl | Blood 90(11):4252-65 (1997) |
| 32 | 1987 | The HLA system: structure and function. |
| + | - | nl | J Clin Pathol 40(9):948-58 (1987) |
| 33 | 2008 | Defining the role of the MHC in autoimmunity: a review and pooled analysis. |
| + | - | nl | PLoS Genet 4(4):e1000024 (2008) |
| 34 | 2009 | HLA and infectious diseases. |
| + | - | nl | Clin Microbiol Rev 22(2):370-85, Table of Contents (2009) |
